KLR

Operating

Kailera Therapeutics ·Cash Flow Statement·32 metrics

Breakdown

Loading...

Metrics

Other non-cash income (expense)

Amortization of Investment Discount and Premium

Accretion (amortization) of discounts and premiums on investments

Other non-cash income (expense)

Change in accounts payable

Change in accrued liabilities

Change in operating lease liabilities

Change in other assets

Change in other liabilities

Other working capital changes

Depreciation and amortization

Accretion (Amortization) of Investment Discounts and Premiums

Other Non-Cash Income (Expense)

Other Non-cash Income (Expense)

Other Non-cash Income (Expense)

Change in other non-current liabilities

Net cash from operating activities

Net income

Other non-cash income (expense)

Accretion (Amortization) of Discounts and Premiums, Investments

Change In Fair Value Of Preferred Stock Tranche Right Liability

Operating lease liabilities

Other current liabilities

Other long-term liabilities

Increase (Decrease) in Prepaid Expense and Other Assets

Noncash Lease Income Expense

Other Noncash Income (Expense)

Other Non-cash Income and Expense

Other Non-Cash Adjustments

Other Non-Cash Income and Expense

Accretion (Amortization) of Investment Discounts and Premiums

Stock-based compensation